- Sort by date
- Hybrid Sort
- Sorted by Smart Random Sort
- Sort by relevance
Advertisements
» Related Searches: cancer, cancer risk, prostate cancer, drug, lung cancer
Results 31 to 40 of 68 
Resource Utilisation and Time Commitment Associated with Correction of Anaemia …
The amount of time and the costs involved in treating cancer-induced anemia can be
significant and should be weighed when choosing a treatment plan. Clinical Drug
Investigation … 
- ├ Alfa Romeo GT en 147 Q2 op video — Autoblog.nl
- ├ Quality care assessment examines surgical quality for … — EurekAlert! - Breaking News
- ├ Fusion Prostate Cancer: An Early Molecular Event … — ScienceDaily Headlines
- └ all 10 related »
North American gets FDA approval for breast cancer treatment
North American Scientific Inc. got approval from the Food and Drug Administration to
market a high-dose radiation design of its breast cancer treatment, the company said
Tuesday …
- ├ North American Gets Cancer Treatment OK — FDA News News from StratCenter.com
- ├ North American Scientific Announces FDA Clearance of … — FDA News News from StratCenter.com
- ├ Cancer treatment of black women delayed — United Press International - Consumer Health
- └ all 10 related »
Bad news for top-selling anemia drugs
A new medical study suggests that high doses of a best- selling drug used to treat
anemia in dialysis and cancer patients may increase the risk of heart problems and …
Patients Respond Well To First Study To Test Higher Doses …
Researchers in the UK and the United States have found that a drug composed of an
antibody carrying a highly toxic anti-cancer agent is well tolerated by patients at
much …
- ├ Patients Respond Well To Higher Doses Of … — Health News from Medical News Today
- ├ Recurrent breast cancer: Drug shows promise — The Cancer Blog
- ├ Drug That Interrupts A Key Stage Of … — Health News from Medical News Today
- └ all 10 related »
Patients Respond Well To Higher Doses Of An Anti-cancer Drug …
… drug composed of an antibody carrying a highly toxic anti-cancer agent is
well tolerated by patients at much higher doses than have been used before. [click link
for full article] …
- ├ Drug That Interrupts A Key Stage Of … — Health News from Medical News Today
- ├ Systemic Treatment Before Surgery For Kidney Cancer … — Health News from Medical News Today
- ├ NICE disapproves the use of cancer drug Tarceva — The Earth Times Online Newspaper
- └ all 10 related »
FDA Expands Use of Herceptin for Early Stage Breast Cancer …
The new indication is for Herceptin, in combination with other cancer drugs, for the
treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy) …
Single-Dose Drug-Loaded Dendrimer Cures Mice of Colon Cancer
… drug delivery vehicle that when loaded with a widely used anticancer agent cures
colon cancer in mice with a single dose …
- ├ Anti-Cancer Tinker Toys — Responsible Nanotechnology
- ├ Risk after colon cancer higher for the … — EurekAlert! - Breaking News
- ├ Very fat/very thin at high colon-cancer risk — United Press International - Health Business
- └ all 10 related »
Adherex posts wider 3Q loss on increased expenses
Cancer drug company Adherex Technologies Inc. said Monday that its third quarter loss
widened in 2006 because of higher operating expenses tied to ongoing clinical trials …
- ├ Kitty Hawk posts wider 3Q loss — bizjournals.com Travel:Airlines & Airports headlines …
- ├ Regency posts larger 3Q loss — Latest news from Dallas Business Journal
- ├ UGS Corp. posts wider 3Q loss — Latest news from Dallas Business Journal
- └ all 10 related »
In brief
… cancer. The lab will start operations next May in temporary premises and then
build a larger facility, which, the Swiss drug company says, will eventually house
400 …
Antigenics: Drug Trips Immune Response
Biotech drug developer Antigenics said its cancer vaccine Oncophage produced a
immune response to cancer of the nervous system …